The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients "EMOTION"

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

Through this study, the investigators are to demonstrate the superiority of Escitalopram over placebo for the prevention of poststroke depression in patients with acute stroke The primary hypothesis of this study is; This study will prove the superiority of Escitalopram on the prevention of poststroke depression in patients with acute stroke against placebo

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 October 2014.

1 Jan 2011 18 Jan 2011 1 Dec 2014 1 Dec 2015 1 Oct 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts